The Efficacy and The Safety of Ultrasound-guided Ablation Therapy for Treating Papillary Thyroid Microcarcinoma

The prevalence of papillary thyroid microcarcinoma (PTMC) increases rapidly all around the world, but the management of PTMC hasn't reached a consensus. Recently, ultrasound-guided (US-guided) ablation therapy was introduced as a feasible treatment for low-risk PTMC. The clinical application of...

Full description

Saved in:
Bibliographic Details
Published inJournal of Cancer Vol. 10; no. 21; pp. 5272 - 5282
Main Authors Chen, Jifan, Cao, Jing, Qiu, Fuqiang, Huang, Pintong
Format Journal Article Book Review
LanguageEnglish
Published Wyoming Ivyspring International Publisher Pty Ltd 01.01.2019
Ivyspring International Publisher
Subjects
Ablation
Biopsy
Cancer therapies
Clinical medicine
Disease
Hospitals
Lasers
Medical prognosis
Medical research
Patients
Review
Thyroid cancer
Tumors
Ultrasonic imaging
Beijing China
Italy
United States > US
China
Japan
Online AccessGet full text

Cover

More Information
Summary:The prevalence of papillary thyroid microcarcinoma (PTMC) increases rapidly all around the world, but the management of PTMC hasn't reached a consensus. Recently, ultrasound-guided (US-guided) ablation therapy was introduced as a feasible treatment for low-risk PTMC. The clinical application of US-guided ablation therapy needs doctors' effort to investigate the efficacy and the safety of US-guided ablation in treating PTMC carefully. Although the present evidence showed some limitations, such as short-term study time spans and no randomized control design, in our perspective, US-guided thermal ablation therapy has good short-term efficacy and safety and is a promising PTMC's treatment in future clinical practice.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Competing Interests: The authors have declared that no competing interest exists.
ISSN:1837-9664
1837-9664
DOI:10.7150/jca.36289